Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness
has sold minority stake to
Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
Our latest transactions
Healthcare & Life Sciences
has sold a minority stake to
Transaction details
Turin-based radiological company Chiron Group has sold a minority stake to KYIP Capital, accelerating the Group’s expansion
Real Estate & Construction
has been acquired by
Transaction details
BridgeFab, a leading structural steel and metalwork companies in Southeast Queensland, has been acquired by McNab
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Cevinio, a European software company specialising in AI-driven automation for Accounts Payable and Accounts Receivable processes, has been sold to Serrala, a global provider of finance process automation software, supporting end-to-end financial operations through a modular, cloud-ready platform
